Hallux Rigidus: Update on Conservative Management.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 39068017.
- Also identified by DOI 10.1016/j.fcl.2023.09.010.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hallux rigidus is a degenerative arthritic condition affecting the first metatarsophalangeal joint. Prevalence in patients aged 50 years and above is estimated at 20% to 30%, with a portion being symptomatic. Conservative treatment's efficacy is linked to initial pain levels; though shoe modifications and insoles are commonly recommended, their true effectiveness lacks strong evidence. Injection therapy, including corticosteroids and hyaluronic acid, demonstrates varied outcomes, with about 50% of patients undergoing surgery within 1 to 2 years. The condition's etiology remains elusive, but recent biomechanical hypotheses hold promise.
Medical subject headings
- Humans
- Hallux Rigidus
- Hallux Rigidus/therapy
- Conservative Treatment
- Conservative Treatment/methods
- Hyaluronic Acid
- Hyaluronic Acid/administration & dosage
- Foot Orthoses
Anatomy
- foot